CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6160-6168

  Pfisterer, Petra ^a   König, Harald ^a,d   Hess, Jochen ^a   Lipowsky, Gerd ^a   Haendler, Bernard ^b   Schleuning, Wolf Dieter ^b   Wirth, Thomas ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Medizinisches Inst F S   (Germany)

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; MOUSE; NONHUMAN; PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

ANIMALIA; MURINAE; STAPHYLOCOCCUS PHAGE 3A;

EID: 0029848759     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.11.6160     Document Type: Article

References (48)

1. Alexander, D., R. M. Goodman, M. Gut-Rella, C. Glascock, K. Weymann, F. L. D. Maddox, P. Ahl-Goy, T. Luntz, E. Ward, and J. Ryals. 1990. Increased tolerance to two oomycete pathogens in transgenic tobacco expressing pathogenesis-related protein 1a. Proc. Natl. Acad. Sci. USA 90: 7327-7331.
2. Annweiler, A., M. Müller-Immerglück, and T. Wirth. 1992. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol. Cell. Biol. 12:3107-3116.
3. Annweiler, A., S. Zwilling, R. A. Hipskind, and T. Wirth. 1193. Analysis of transcriptional stimulation by recombinant Oct proteins in a cell free system. J. Biol. Chem. 268:2525-2534.
4. Annweiler, A., S. Zwilling, and T. Wirth. 1994. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res. 22:4250-4258.
5. Brooks, D. E., and K. Tiver. 1983. Localization of epididymal secretory proteins on rat spermatozoa. J. Reprod. Fertil. 69:651-657.
6. Charest, N. J., D. R. Joseph, E. M. Wilson, and F. S. French. 1988. Molecular cloning of complementary deoxyribonucleic acid for an androgen-regulated epididymal protein: sequence homology with metailoproteins. Mol. Endocrinol. 2:999-1004.
7. 1 progression and for proliferation. Immunity 1:635-645.
8. Corcoran, L. M., M. Karvelas, G. J. V. Nossal, Z.-S. Ye, T. Jacks, and D. Baltimore. 1993. Oct-2. although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:570-582.
9. Cornelissen, B. J. C., J. Horowitz, J. A. L. van Kan, K. B. Goldberg, and J. F. Bol. 1987. Structure of tobacco genes encoding pathogenesis-related proteins from the PR-1 group. Nucleic Acids Res. 15:6799-6811.
10. Eberspaecher, U., D. Roosterman, J. Krätzschmar, B. Haendler, U-F. Habenicht, A. Becker, C. Quensel, T. Petri, W.-D. Schleunig, and P. Donner. 1995. Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE/AEG): isolation, biochemical characterization, and expression in recombinant form. Mol. Reprod. Dev. 42:157-172.
11. Falkner, F. G., and H. G. Zachau. 1984. Correct transcription of an immunoglobulin K gene requires an upstream fragment containing conserved sequence elements. Nature (London) 310:71-74.
12. Feldbaus, A. L., C. A. Klug, K. L. Arvin, and H. Singh. 1993. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J. 12:2763-2772.
13. Gerster, T., C.-G. Balmaceda, and R. G. Roeder. 1990. The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription. EMBO J. 9:1635-1643.
14. Gstaiger, M., L. Knoepfel, O. Georgier, W. Schaffner, and C. M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature (London) 373:360-362.
15. Haendler, B., J. Krätzschmar, F. Theuring, and W.-D. Schleuning. 1993. Transcripts for cysteine-rich secretory protein-1 (CRISP-1; DE/AEG) and a novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology 133:192-198.
16. Hardy, D. M., T. T. F. Huang, W. J. Driscoll, K. S. K. Tung, and G. C. Wild. 1988. Purification and characterization of the primary acrosomal autoantigen of guinea pig epididymal spermatozoa. Biol. Reprod. 38:423-437.
17. Herr, W., and M. Cleary. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1679-1693.
18. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, and H. R. Horvitz. 1988. The POU domain: a large conserved region in the mammalian pit-1, on-1, Ort-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513-1516.
19. Kasahara, M., J. Gutknecht, K. Brew, N. Spurr, and P. N. Goodfellow. 1989. Cloning and mapping of a testis-specific gene with sequence similarity to a sperm-coating glycoprotein gene. Genomics 5:527-534.
20. Kistler, B., and T. Wirth. 1995. Lymphoid- and myeloid-specific activity is determined by the combinatorial action of octamer and ets transcription factors. Oncogene 11:1095-1106.
21. König, H., P. Pfisterer, L. Corcoran, and T. Wirth. 1995. Identification of CD36 as the first gene dependent on the B cell differentiation factor Oct2. Genes Dev. 9:1598-1607.
22. König, H., H. Ponta, U. Rahmsdorf, M. Büscher, A. Schönthal, H. J. Rahmsdorf, and P. Herrlich. 1989. Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J. 8:2559-2566.
23. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (London) 365:767-770.
24. Luo, Y., H. Fujii, T. Gerster, and R. G. Roeder. 1992. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71:231-241.
25. Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115-4124.
26. Mochca-Morales, J., B. M. Martin, and L. D. Possani. 1990. Isolation and characterization of helothermine, a novel toxin from Heloderma horridum horridum (Mexican beaded lizard) venom. Toxicon 28:299-309.
27. Morrissette, J., J. Krätzschmar, R. El-Hayek, J. Mochca-Morales, B. M. Martin, J. R. Patel, R. L. Moss, W.-D. Schleunig, R. Coronado, and L. D. Possani. 1995. Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys. J. 68:2280-2288.
28. Müller-Immerglück, M. M., W. Schaffner, and P. Matthias. 1990. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 9:1625-1634.
29. Parslow, T. G., D. L. Blair, W. J. Murphy, and D. K. Granner. 1984. Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650-2654.
30. 29a. Pfisterer, P. Data not shown.
31. Pfisterer, P., A. Annweiler, C. Ullmer, L. Corcoran, and T. Wirth. 1994. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 13:1654-1663.
32. Pfisterer, P., S. Zwilling, J. Hess, and T. Wirth. 1995. Functional characterization of the murine homolog of the B-cell-specitic coactivator BOB.1/OBF.1. J. Biol. Chem. 270:29870-29880.
33. Rigden, J., and R. Coutts. 1988. Pathogenesis-related proteins in plants. Trends Genet. 4:87-89.
34. Rosenfeld, M. G. 1991. POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev. 5:897-907.
35. Schwidetzky, U., B. Haendler, and W.-D. Schleunig. 1995. Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (CRISP-3) gene. Biochem. J. 309:831-836.
36. Staudt, L. M., R. G. Clerc, H. Singh, J. H. LeBowitz, P. A. Sharp, and D. Baltimore. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241:577-580.
37. Staudt, L. M., and M. J. Lenardo. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:373-398.
38. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer proteins. Cell 80:497-506.
39. Sturm, R. A., G. Das, and W. Herr. 1988. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 2:1582-1599.
40. Sturm, R. A., and W. Herr. 1988. The POU domain is a bipartite DNA-binding structure. Nature (London) 336:601-604.
41. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386.
42. Tanaka, M., J.-S. Lai, and W. Herr. 1992. Promoter-selective activation domains in Oct-1 and Oct2 direct differential activation of an snRNA and mRNA promoter. Cell 68:755-767.
43. Verrijzer, C. P., M. J. Alkema, W. W. van Weperen, H. C. van Leeuwen, M. J. J. Strating, and P. C. van der Vliet. 1992 The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11:4993-5003.
44. Webster, N. J. G., S. Green, J. Rui Jin, and P. Chambon. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transactivation function. Cell 54:199-207.
45. Wirth, T., P. Pfisterer, A. Annweiler, S. Zwilling, and H. König. 1995 Molecular principles of Oct2-mediated gene activation in B cells. Immunobiology 193:161-170.
46. Wirth, T., A. Priess, A. Annweiler, S. Zwilling, and B. Oeler. 1991. Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res. 19:43-51.
47. Wirth, T., L. Staudt, and D. Baltimore. 1987. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (London) 329:174-178.
48. Zwilling, S., H. König, and T. Wirth. 1995. HMG2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14:1198-1208.